These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37434651)

  • 1. Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma.
    Lider Burciulescu SM; Randon C; Duprez F; Huvenne W; Creytens D; Claes KBM; de Putter R; T'Sjoen G; Badiu C; Lapauw B
    Endocr Oncol; 2023 Jan; 3(1):e220040. PubMed ID: 37434651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
    Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
    Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.
    Waguespack SG; Rich T; Grubbs E; Ying AK; Perrier ND; Ayala-Ramirez M; Jimenez C
    J Clin Endocrinol Metab; 2010 May; 95(5):2023-37. PubMed ID: 20215394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1.
    Gruber LM; Erickson D; Babovic-Vuksanovic D; Thompson GB; Young WF; Bancos I
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):141-149. PubMed ID: 27460956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas?
    Iacobone M; Schiavi F; Bottussi M; Taschin E; Bobisse S; Fassina A; Opocher G; Favia G
    Surgery; 2011 Dec; 150(6):1194-201. PubMed ID: 22136840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
    Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma.
    Gupta P; Khurana ML; Khadgawat R; Bal CS; Kumar G; Sharma SC; Tandon N
    Indian J Endocrinol Metab; 2015; 19(5):633-8. PubMed ID: 26425473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
    Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
    Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.
    Opotowsky AR; Moko LE; Ginns J; Rosenbaum M; Greutmann M; Aboulhosn J; Hageman A; Kim Y; Deng LX; Grewal J; Zaidi AN; Almansoori G; Oechslin E; Earing M; Landzberg MJ; Singh MN; Wu F; Vaidya A
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1325-34. PubMed ID: 25581599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention Deficit Hyperactivity Disorder in Pediatric Patients with Pheochromocytoma and Paraganglioma.
    Batsis M; Dagalakis U; Stratakis CA; Prodanov T; Papadakis GZ; Adams K; Lodish M; Pacak K
    Horm Metab Res; 2016 Aug; 48(8):509-13. PubMed ID: 27171833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas.
    Fernandez MC; Martin A; Venara M; Calcagno Mde L; Sansó G; Quintana S; Chemes HE; Barontini M; Pennisi PA
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):623-30. PubMed ID: 23506534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pediatric pheochromocytoma and paraganglioma: an update].
    Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
    Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.
    Goffredo P; Sosa JA; Roman SA
    J Surg Oncol; 2013 May; 107(6):659-64. PubMed ID: 23233320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
    Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
    Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3P association (3PAs): Pituitary adenoma and pheochromocytoma/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations.
    Guerrero-Pérez F; Fajardo C; Torres Vela E; Giménez-Palop O; Lisbona Gil A; Martín T; González N; Díez JJ; Iglesias P; Robledo M; Villabona C
    Eur J Intern Med; 2019 Nov; 69():14-19. PubMed ID: 31431315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden.
    Muth A; Abel F; Jansson S; Nilsson O; Ahlman H; Wängberg B
    World J Surg; 2012 Jun; 36(6):1389-94. PubMed ID: 22270996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
    Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
    PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary Diseases Predisposing to Pheochromocytoma (VHL, NF-1, Paraganglioma Syndromes, and Novel Genes).
    Sarkadi B; Patócs A
    Exp Suppl; 2019; 111():129-147. PubMed ID: 31588531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing in pheochromocytoma or functional paraganglioma.
    Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
    J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary Pheochromocytoma.
    Santos P; Pimenta T; Taveira-Gomes A
    Int J Surg Pathol; 2014 Aug; 22(5):393-400. PubMed ID: 24903423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.